Ignite Creation Date:
2025-12-25 @ 2:18 AM
Ignite Modification Date:
2026-01-03 @ 8:35 PM
Study NCT ID:
NCT02923934
Status:
COMPLETED
Last Update Posted:
2024-07-24
First Post:
2016-10-02
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
A Phase II Trial of Ipilimumab and Nivolumab for the Treatment of Rare Cancers
Sponsor:
Olivia Newton-John Cancer Research Institute
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2017-08-22
Start Date Type:
ACTUAL
Primary Completion Date:
2020-04-27
Primary Completion Date Type:
ACTUAL
Completion Date:
2023-12-12
Completion Date Type:
ACTUAL
First Submit Date:
2016-10-02
First Submit QC Date:
None
Study First Post Date:
2016-10-05
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2024-07-23
Last Update Post Date:
2024-07-24
Last Update Post Date Type:
ACTUAL